Letter to the Editor: Clinical versus statistical significance of pharmacogenomic-guided antidepressant therapy: What's really being measured and marketed?
1 Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: joseph.goldberg@mssm.edu.
2 Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, University of Toronto, Toronto, Ontario, Canada.
3 Department of Psychiatry, Kansas University School of Medicine-Wichita, Wichita, KS, USA.
4 University of Kentucky Mental Health Research Center at Eastern State Hospital, Lexington, KY, USA; Psychiatry and Neurosciences Research Group (CTS-549), Institute of Neurosciences, University of Granada, Granada, Spain; Biomedical Research Centre in Mental Health Net (CIBERSAM), Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain.